GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Techno Drugs Ltd (DHA:TECHNODRUG) » Definitions » Operating Margin %

Techno Drugs (DHA:TECHNODRUG) Operating Margin % : 17.82% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Techno Drugs Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Techno Drugs's Operating Income for the three months ended in Dec. 2024 was BDT163 Mil. Techno Drugs's Revenue for the three months ended in Dec. 2024 was BDT914 Mil. Therefore, Techno Drugs's Operating Margin % for the quarter that ended in Dec. 2024 was 17.82%.

The historical rank and industry rank for Techno Drugs's Operating Margin % or its related term are showing as below:

DHA:TECHNODRUG' s Operating Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 17.44
Current: 17.44


DHA:TECHNODRUG's Operating Margin % is ranked better than
77.47% of 972 companies
in the Drug Manufacturers industry
Industry Median: 6.9 vs DHA:TECHNODRUG: 17.44

Techno Drugs's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Techno Drugs's Operating Income for the three months ended in Dec. 2024 was BDT163 Mil.


Techno Drugs Operating Margin % Historical Data

The historical data trend for Techno Drugs's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Techno Drugs Operating Margin % Chart

Techno Drugs Annual Data
Trend
Operating Margin %

Techno Drugs Quarterly Data
Sep23 Dec23 Sep24 Dec24
Operating Margin % 14.95 18.31 17.10 17.82

Competitive Comparison of Techno Drugs's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Techno Drugs's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Techno Drugs's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Techno Drugs's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Techno Drugs's Operating Margin % falls into.


;
;

Techno Drugs Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Techno Drugs's Operating Margin % for the fiscal year that ended in . 20 is calculated as

Operating Margin %=Operating Income (A: . 20 ) / Revenue (A: . 20 )
= /
= %

Techno Drugs's Operating Margin % for the quarter that ended in Dec. 2024 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=162.773 / 913.512
=17.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Techno Drugs  (DHA:TECHNODRUG) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Techno Drugs Operating Margin % Related Terms

Thank you for viewing the detailed overview of Techno Drugs's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Techno Drugs Business Description

Traded in Other Exchanges
N/A
Address
31 Segun Bagicha, J K Tower, Dhaka, BGD, 1000
Techno Drugs Ltd is a pharmaceutical company. The company manufactures medicines for the healthcare market with quality products, a distribution channel, and doctor-patient acceptance. The company is also engaged in production of Anti-Cancer medicines and medicines for therapeutic areas like oncology, cardiovascular, diabetes, immune suppressor, anesthetics, life-saving antibiotics & contrast media in Bangladesh. The product portfolio of the company include Algicar Plus, Amoclav Forte, Adesol Oral Solution, Aminovet Injection, Apegestrol Tab, Docetex 20 Inj, and others.

Techno Drugs Headlines

No Headlines